Genesis Healthcare, Inc. GENNQ
- Market cap
- —
- P/E
- 0.0×
Follow GENNQ
Target Price Range
Analyst price targets
Free account| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 1.38 | 0.60 | 0.73 | 0.92 | 0.40 |
Analyst estimates 2021–2023 Powerpack |
Low Price
|
||
| — | — | — | — | — | 4.44 | 4.75 | 2.86 | 1.79 | 1.86 |
High Price
|
|||
| — | — | — | — | — | 82,000 | 68,700 | 61,300 | 55,000 | 44,000 |
Employees
|
|||
| — | — | — | — | — | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | 5,732 | 5,374 | 4,977 | 4,566 | 3,906 |
Revenue
|
|||
| — | — | — | — | — | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Gross Margin
|
|||
| — | — | — | — | — | (136) | (970) | (375) | 9 | (107) |
EBT
|
|||
| — | — | — | — | — | (2.36%) | (18.04%) | (7.53%) | 0.20% | (2.74%) |
EBT Margin
|
|||
| — | — | — | — | — | (118) | (959) | (372) | 7 | (103) |
Net Income
|
|||
| — | — | — | — | — | 258 | 616 | 224 | 123 | 108 |
Depreciation
|
|||
| — | — | — | — | — | 63.78 | 57.04 | 49.27 | 42.56 | 34.92 |
Revenue/Sh
|
|||
| — | — | — | — | — | (0.71) | (6.15) | (2.33) | 0.14 | (0.35) |
Earnings/Sh
|
|||
| — | — | — | — | — | 0.76 | 1.28 | 0.18 | (0.07) | 2.82 |
Cash Flow/Sh
|
|||
| — | — | — | — | — | (0.56) | 0.28 | 0.23 | (3.70) | (0.03) |
Capex/Sh
|
|||
| — | — | — | — | — | 0.20 | 1.56 | 0.41 | (3.76) | 2.79 |
Free CF/Sh
|
|||
| — | — | — | — | — | (8.12) | (17.83) | (20.24) | (10.09) | (10.39) |
Book Value/Sh
|
|||
| — | — | — | — | — | 90 | 94 | 101 | 107 | 112 |
Shares
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 13.67 | 0.00 |
PE Ratio
|
|||
| — | — | — | — | — | 0.07 | 0.01 | 0.02 | 0.04 | 0.01 |
PS Ratio
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio
|
|||
| — | — | — | — | — | 0.93 | 0.93 | 0.98 | 0.38 | 0.34 |
EV/Sales
|
|||
| — | — | — | — | — | 303.03 | 34.18 | 117.14 | (4.27) | 4.25 |
EV/FCF
|
|||
| — | — | — | — | — | 68 | 120 | 19 | (7) | 316 |
Op' Cash Flow
|
|||
| — | — | — | — | — | (51) | 26 | 23 | (397) | (3) |
Capex
|
|||
| — | — | — | — | — | 18 | 147 | 42 | (404) | 312 |
FCF
|
|||
| — | — | — | — | — | 201 | 41 | (37) | (242) | (2,976) |
Working Cap'
|
|||
| — | — | — | — | — | 5,038 | 5,034 | 4,908 | 1,656 | 1,579 |
Total Debt
|
|||
| — | — | — | — | — | 4,943 | 4,942 | 4,778 | 1,549 | 1,277 |
Net Debt
|
|||
| — | — | — | — | — | (730) | (1,680) | (2,045) | (1,083) | (1,162) |
Sh' Equity
|
|||
| — | — | — | — | — | (1.08%) | (10.96%) | (5.20%) | 0.33% | (1.35%) |
ROA
|
|||
| — | — | — | — | — | 4.49% | (7.21%) | 1.58% | 1.09% | (267.94%) |
ROIC
|
|||
| — | — | — | — | — | 9.49% | 48.04% | 12.63% | (0.93%) | 5.25% |
ROE
|
|||
Genesis Healthcare, Inc. (GENNQ) Latest News
19 Dec
Genesis Healthcare, Inc. has received third-party recognition for its commitment to excellence in skilled nursing care, highlighting its dedication to quality services and patient outcomes. This acknowledgment reflects the company's ongoing efforts to enhance care standards and improve the overall experience for residents and their families. Recognition from third parties can positively influence the company's reputation and operational focus.
12 Dec
Genesis Healthcare, Inc. (GENNQ) is focused on achieving long-term stability through strategic initiatives aimed at enhancing operational efficiency and financial performance. The company is committed to improving patient care and expanding its service offerings, which are expected to contribute positively to its market position. Ongoing efforts to adapt to industry changes and regulatory requirements are also highlighted as key components of its strategy for sustained growth. Strategic initiatives aimed at operational efficiency and financial performance are likely to significantly impact the company's future trajectory.
11 Nov
Democratic lawmakers have raised concerns regarding a recent insider sale by Genesis Healthcare, Inc. (GENNQ), suggesting it may exploit the bankruptcy system. They argue that the transaction could undermine the integrity of the bankruptcy process and potentially harm creditors and employees. The lawmakers are calling for investigations into the sale to ensure compliance with bankruptcy laws and to protect stakeholders' interests. Concerns over insider sales during bankruptcy could moderately influence investor sentiment and regulatory scrutiny.
10 Oct
Genesis Healthcare, Inc. (GENNQ) has filed for Chapter 11 bankruptcy, marking a significant development for the major health care product company. The filing indicates financial distress and a restructuring effort aimed at addressing its debts and operational challenges. This move may impact its ability to continue operations and fulfill obligations to creditors and stakeholders. Filing for Chapter 11 bankruptcy is likely to significantly impact the company's future operations and market performance.
14 Jul
Genesis Healthcare, Inc., the parent company of Santa Fe's Casa Real nursing home, has filed for bankruptcy. This move comes amid ongoing financial struggles faced by the company, which has been impacted by the challenges in the healthcare sector, particularly in long-term care facilities. The bankruptcy filing raises concerns about the future operations of Casa Real and its ability to continue providing care to residents. Stakeholders are now left to assess the implications of this development on the local community and the broader healthcare landscape. The bankruptcy filing is likely to significantly impact the company's operations and investor sentiment.
12 Jul
Genesis Healthcare, Inc. (GENNQ) faces a wave of downgrades from analysts, marking the worst period of such actions since 2021. This trend reflects growing concerns about the company's financial health and market position, potentially leading to decreased investor confidence and market performance. The significant downgrades indicate major concerns about the company's financial stability and future performance.